Latest Commercialization News

Australian Vintage Limited reported a strong FY25 with significant profit growth despite flat revenue, underpinned by innovation and cost-cutting initiatives. The company aims for positive free cash flow in FY26, propelled by global brand expansion and operational efficiencies.

Nex Metals Explorations has partnered with the Wangkatja Tjungula Aboriginal Corporation to reprocess historic gold tailings at Kookynie, sharing profits and embedding cultural stewardship in rehabilitation efforts.

Elanor Commercial Property Fund's Independent Board Committee has unanimously recommended that securityholders reject the unsolicited takeover offer from Lederer Group, citing undervaluation and lack of control premium.

Orbital Corporation reveals a strategic pivot amid evolving US drone policies, with a new management team driving growth beyond Boeing Insitu. FY25 guidance shows revenue decline but promising new contracts.

Orbital UAV secures $3 million through a share placement to boost manufacturing capabilities and expand business development amid new US drone market opportunities.

Objective Corporation reports robust FY2025 results with strong recurring revenue growth and deepening AI integration, setting ambitious targets for FY2026.

RooLife Group Ltd (ASX, RLG) has launched its proprietary RLG Coffee brand in China, tapping into a rapidly expanding market with early sales exceeding $110,000 in the first month. Strategic partnerships and a recent supply deal position RLG for broader growth in the country’s evolving consumer landscape.

Papyrus Australia clarifies it has signed a binding term sheet, not a final agreement, with AQN for biodegradable boards, contingent on facility setup and product testing.

Vanadium Resources Limited is progressing towards Direct Shipping Ore operations at Steelpoortdrift, advancing key conditions for a binding offtake agreement with China Precious Asia Limited while optimizing mining readiness and exploring growth opportunities.

TMK Energy has completed commissioning its LF-07 pilot well at the Gurvantes XXXV Coal Seam Gas Project, joining six other wells in production as the company shifts focus to optimising output and reservoir management.

Tryptamine Therapeutics has secured an exclusive agreement with leading neuroscientists to develop a novel EEG-based brain entropy biomarker aimed at enhancing precision psychiatry for its psychedelic drug TRP-8803.

Medical Developments International Ltd reported an 18% increase in revenue to $39.1 million for FY25, returning to profitability with a net profit after tax of $0.1 million. The company advanced its Penthrox market expansion through regulatory approvals and new partnerships.